(RS)-1-hydroxyethyl (6R,7R)-7-[2-(2-furyl)glyoxyl-amido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]-oct-2-ene-2-carboxylate, 72-(Z)-(O-methyl-oxime), 1-acetate 3-carbamate. C₂₀H₂₂N₄O₁₀S
125mg twice a day for 7 days.
Reconstituted with previously boiled and cooled water according to label instructions.
Absorption is enhanced when taken after food.
It is hydrolyzed to cefuroxime, which inhibits bacterial cell-wall synthesis.
Gastrointestinal disturbances (diarrhea, nausea, vomiting, abdominal pain).
Patients with a known allergy to cephalosporin antibiotics.
Caution in patients with concurrent potent diuretics, history of colitis or gastrointestinal malabsorption. Prolonged use may lead to superinfection.
Unchanged in the urine.
Below 30°C, protected from light and moisture, and out of reach of children.
Increases the serum concentration-time curve by 50%.
Pharyngitis/Tonsillitis, Acute Bacterial Otitis Media, Acute Bacterial Maxillary Sinusitis, Acute Bacterial exacerbations of Chronic Bronchitis and Secondary Bacterial Infections of acute bronchitis, Uncomplicated Skin and Skin-Structure Infections, Uncomplicated Urinary Tract Infections, Uncomplicated Gonorrhea (urethral and endocervical), and Early Lyme Disease (erythema migrans).